In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.
Contains 14 relevant, practice-oriented topics including diabetes, cachexia, sarcopenia, and metabolic factors in individuals with pancreatic adenocarcinoma; PARP inhibitors and other novel therapeutics in pancreatic adenocarcinoma; screening and surveillance for pancreatic adenocarcinoma in high-risk individuals; germline testing for individuals with pancreatic adenocarcinoma and novel genetic risk factors; and more.
Provides in-depth clinical reviews on pancreatic cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes - p. 879 9. The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes - p. 897 10. What Can We Learn About Pancreatic Adenocarcinoma from Imaging? - p. 911 11. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals - p. 929 12. Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors - p. 943 13. Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma - p. 961 14. Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma - p. 979 15. Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon - p. 995 16. Cytotoxic Chemotherapy in Advanced Pancreatic Cancer - p. 1011 17. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma - p. 1019 18. Genetics of Pancreatic Neuroendocrine Tumors - p. 1033 19. Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma - p. 1053
In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.
Contains 14 relevant, practice-oriented topics including diabetes, cachexia, sarcopenia, and metabolic factors in individuals with pancreatic adenocarcinoma; PARP inhibitors and other novel therapeutics in pancreatic adenocarcinoma; screening and surveillance for pancreatic adenocarcinoma in high-risk individuals; germline testing for individuals with pancreatic adenocarcinoma and novel genetic risk factors; and more.
Provides in-depth clinical reviews on pancreatic cancer, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Pancreatic Adenocarcinoma: Trends in Epidemiology, Risk Factors, and Outcomes - p. 879 9. The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes - p. 897 10. What Can We Learn About Pancreatic Adenocarcinoma from Imaging? - p. 911 11. Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals - p. 929 12. Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors - p. 943 13. Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma - p. 961 14. Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma - p. 979 15. Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon - p. 995 16. Cytotoxic Chemotherapy in Advanced Pancreatic Cancer - p. 1011 17. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma - p. 1019 18. Genetics of Pancreatic Neuroendocrine Tumors - p. 1033 19. Palliative and Supportive Care for Individuals with Pancreatic Adenocarcinoma - p. 1053
